International Journal of Molecular Sciences
Cure8 research brief
Why This Matters
Researchers are exploring antioxidant strategies for colitis because oxidative stress contributes to mucosal damage; preclinical positive signals could eventually lead to new adjunctive therapies for ulcerative colitis after further testing.
Who Should Pay Attention
Researchers studying IBD pathophysiology or drug discovery, clinicians interested in experimental antioxidant strategies, and translational scientists planning preclinical-to-clinical work.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This study tested the antioxidant and anti-inflammatory effects of N‑acetylcysteine (NAC), the antioxidant Tiron, and a fixed‑ratio NAC–Tiron combination in cell-based assays and a rat model of acetic acid‑induced ulcerative colitis.
In vitro assays and molecular docking indicated antioxidant activity, and short‑term pretreatment reduced macroscopic and histological colon injury, inflammatory infiltration, oxidative‑damage markers, and some systemic inflammatory indicators in rats.
The report frames these findings as an exploratory proof of concept using animal and acellular models; it does not claim clinical benefit in people or compare these treatments against standard UC therapies in human trials. Safety and dosing in humans are not addressed here.
If you have UC and are curious about antioxidants, discuss any supplements or experimental approaches with your clinician before use. This paper supports further preclinical research but does not provide evidence to change clinical care at this time.
Keep In Mind
Structured-content depth: abstract. This is an animal (rat) and in vitro study reported in a molecular‑science journal; it is exploratory and does not establish efficacy or safety in humans. The article itself notes it does not demonstrate superiority over standard therapies.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationInternational Journal of Molecular Sciences
PublisherMDPI AG
AuthorsAhmed Kouki, Dorsaf Bouzazi, Asma Trabelsi +8 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedAug 10, 2026, 12:00 AM
Content availableJournal abstract
Funding disclosed by the source: University of Bologna
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Chemical Profiling of Commiphora gileadensis, Salsola incanescens, and Savignya parviflora and Their Protective Effects in an Acute Rat Model of Ulcerative Colitis
This study identifies plant extracts—especially Commiphora gileadensis—that reduced inflammation and tissue injury in cell assays and an acute rat model of ulcerative colitis, suggesting new leads for future IBD drug...
n-Hexane extract of Anacardium occidentale ameliorates spatial memory impairment, anxiety, and depressive-like behavior through the suppression of gut-brain inflammation and cholinergic disruption in acetic acid-induced experimental colitis
IBD is linked with mood and cognitive symptoms via systemic and gut‑brain inflammation, so preclinical findings that a cashew kernel extract reduced inflammation and behavioral changes could point to new research...
Anti-Inflammatory Components of Artemisia scoparia Alleviate Ulcerative Colitis: An Integrated Study Combining UPLC-Q-Exactive Orbitrap MS/MS, Network Pharmacology, Molecular Docking, and In Vivo/In Vitro Validation
The study identifies specific anti-inflammatory compounds in Artemisia scoparia and shows they reduce inflammation in cell and mouse models of ulcerative colitis, suggesting potential new leads for drug or...